| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/30/1997 | WO1997002824A1 Use of a tachykinin antagonist and a muscarinic antagonist and/or an antihistamine to treat motion sickness |
| 01/30/1997 | WO1997002817A1 Compounds useful in the treatment of neurofibromatosis |
| 01/30/1997 | WO1997002813A1 Non-allosteric gabaa agonists for treating sleep disorders |
| 01/30/1997 | WO1996033724A3 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 01/30/1997 | CA2226658A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | CA2226623A1 Compounds useful in the treatment of neurofibromatosis |
| 01/29/1997 | EP0755925A1 N,N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene-diamine derivatives and their use in pharmaceutical and cosmetic compositions |
| 01/29/1997 | EP0755675A1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 01/29/1997 | EP0755633A1 Two phases preparation |
| 01/29/1997 | EP0755265A1 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure |
| 01/29/1997 | EP0755255A1 Treatment of toxoplasmosis |
| 01/29/1997 | EP0755252A1 Method of treating allergic rhinitis |
| 01/29/1997 | EP0755249A1 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease |
| 01/29/1997 | EP0727978A4 Topical aromatic releasing compositions |
| 01/29/1997 | EP0493446B1 Treatment of autoimmune disease |
| 01/29/1997 | CN1141196A Application of quinoxalines in combination with protease inhibitors as medicaments |
| 01/29/1997 | CA2182226A1 Dermatological or pharmaceutical composition; process for preparing and uses |
| 01/28/1997 | US5597928 Retroviral protease inhibiting compounds |
| 01/28/1997 | US5597927 Retroviral protease inhibiting compounds |
| 01/28/1997 | US5597898 NF-κB activation regulatory protein, IκB-β |
| 01/28/1997 | US5597826 Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
| 01/28/1997 | US5597818 Methods of treating cardiac arrhythmia |
| 01/28/1997 | US5597809 Methyl aspartate mediated retinal cell damage |
| 01/28/1997 | US5597699 Method for determining drug compositions to prevent desensitization of cellular receptors |
| 01/28/1997 | CA2061270C Method and composition for treating reperfusion injury |
| 01/27/1997 | CA2182113A1 N,n'-di(aralkyl) n,n'-di(2-azaaralkyl) alkylene diamine derivatives and their use in pharmaceutical and cosmetic compositions |
| 01/23/1997 | WO1997002046A2 Saccharide conjugates |
| 01/23/1997 | WO1997002045A1 Therapeutic agents and autoimmune diseases |
| 01/23/1997 | WO1997002039A1 Antibacterial synergistic composition comprising rifabutin |
| 01/23/1997 | WO1997002038A1 Silver-based pharmaceutical compositions |
| 01/23/1997 | WO1997002032A1 Method of treating renal disease using an ace inhibitor and an aii antagonist |
| 01/23/1997 | WO1997002024A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
| 01/23/1997 | WO1997002023A1 USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS |
| 01/23/1997 | WO1997002021A1 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors |
| 01/23/1997 | WO1997002020A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 01/23/1997 | WO1997002016A1 Preparations and methods for the treatment of t cell mediated diseases |
| 01/23/1997 | WO1996040258A3 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 01/23/1997 | WO1996040255A3 Method to treat cardiofibrosis with a combination therapy of an angiotensin ii antagonist and an epoxy-steroidal aldosterone antagonist |
| 01/23/1997 | WO1996040250A3 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 01/23/1997 | WO1996040168A3 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 01/23/1997 | WO1996038558A3 A human purinergic p2u receptor |
| 01/23/1997 | WO1996028151A3 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs |
| 01/23/1997 | CA2587000A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 01/23/1997 | CA2225668A1 Use of stat 6 sh2 domain specific compounds to treat allergic reactions |
| 01/23/1997 | CA2225666A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
| 01/23/1997 | CA2224451A1 Method of treating renal disease using an ace inhibitor and an aii antagonist |
| 01/22/1997 | EP0754191A1 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 01/22/1997 | EP0754069A1 Methods for treating pulmonary vasoconstriction and asthma |
| 01/22/1997 | EP0754061A1 New oral pharmaceutical dosage form |
| 01/22/1997 | EP0754060A1 NEW COMBINATION OF A $g(b)-RECEPTOR BLOCKER AND A LOCAL ANAESTHETIC |
| 01/22/1997 | EP0754059A1 Methods and compositions useful for inhibition of angiogenesis |
| 01/22/1997 | EP0754052A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 01/22/1997 | EP0754050A1 Anti-gram-positive bacterial methods and materials |
| 01/22/1997 | EP0754049A1 Anti-fungal methods and materials |
| 01/22/1997 | EP0754042A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |
| 01/22/1997 | EP0754036A1 Permanently ionic derivatives of steroid hormones and their antagonists |
| 01/22/1997 | CN1140999A Anti-fungal methods and materials |
| 01/22/1997 | CN1140997A Vanadate compounds for the treatment of proliferative disorders metastases and drug resistant tumors |
| 01/21/1997 | US5596011 Administering a glutathione enhancing agent |
| 01/21/1997 | US5595997 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 01/21/1997 | US5595985 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 01/21/1997 | US5595973 Protection of hemopoietic cells during chemotherapy or radiotherapy |
| 01/21/1997 | US5595764 Calcium carbonate or sulfate dispersed in petrolatum |
| 01/21/1997 | CA2033249C Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures |
| 01/16/1997 | WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | WO1997001352A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 01/16/1997 | WO1997001351A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 01/16/1997 | WO1997001344A2 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 01/16/1997 | WO1997001275A1 Combinations of inhibitors of farnesyl-protein transferase |
| 01/16/1997 | WO1996036318A3 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application |
| 01/16/1997 | WO1996027378A3 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/16/1997 | DE19525598A1 Schlafmittel Sleeping pills |
| 01/16/1997 | CA2225691A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 01/16/1997 | CA2225682A1 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 01/16/1997 | CA2225255A1 Combinations of inhibitors of farnesyl-protein transferase |
| 01/16/1997 | CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/15/1997 | EP0753301A1 Combination of benzimidazoles having angiotensin-II antagonistic activity with diuretics |
| 01/15/1997 | EP0753298A1 Synergistic combination comprising an insulin sensitizer and a HMG-CoA reductase inhibitor for treating arteriosclerosis |
| 01/15/1997 | EP0753071A1 Cell-targeted lytic pore-forming agents |
| 01/15/1997 | EP0752872A1 Nadh oxidase as a target in diagnosis and therapy |
| 01/15/1997 | EP0752859A1 Pharmaceutical composition containing a class iii antiarrhythmic agent and a class iv antiarrhythmic agent |
| 01/15/1997 | EP0752858A1 Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction |
| 01/15/1997 | EP0752851A1 New pharmaceutical formulation and process |
| 01/15/1997 | EP0752813A1 Inhibitors of metazoan parasite proteases |
| 01/15/1997 | EP0478694B1 use of pirenzepine, telenzepine oder O-methoxy -sila-hexocyclium in the manufacture of a medicament for the TREATMENT AND CONTROL OF OCULAR DEVELOPMENT |
| 01/15/1997 | EP0372070B1 Method for making solvent dilution microcarriers |
| 01/15/1997 | CN1140409A Treatment of normotensive glaucoma with angiotensin II antagonisto |
| 01/14/1997 | US5593993 Method for inhibition of HIV related viruses |
| 01/14/1997 | US5593693 Effervescent mixture with alkali metal salts or lysinates of acidic, insoluble or slightly soluble active ingredients |
| 01/14/1997 | US5593658 Medical compositions |
| 01/09/1997 | WO1997000952A2 A human edg-2 receptor homolog |
| 01/09/1997 | WO1997000860A1 Cb2 receptor agonist compounds |
| 01/09/1997 | WO1997000695A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | WO1997000692A1 ANALGESIC USE OF N-L-α-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER |
| 01/09/1997 | WO1997000677A1 Use of ubenimex and the pharmaceutical composition containing it for treating virus hepatitis |
| 01/09/1997 | WO1997000670A1 A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 01/09/1997 | DE19524515A1 Saccharid-Konjugate Saccharide conjugates |
| 01/09/1997 | CA2225517A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | CA2225462A1 Analgesic use of n-l-.alpha.-aspartyl-l-phenylalanine 1-methyl ester |
| 01/09/1997 | CA2225379A1 Cb2 receptor agonist compounds |